Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  SI-BONE, Inc.    SIBN

SI-BONE, INC.

(SIBN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/06/2020 07/07/2020 07/08/2020 07/09/2020 07/10/2020 Date
15.9(c) 15.78(c) 15.75(c) 15.69(c) 15.68(c) Last
141 428 107 934 143 742 175 939 110 624 Volume
-1.30% -0.75% -0.19% -0.38% -0.06% Change
More quotes
Financials (USD)
Sales 2020 61,3 M - -
Net income 2020 -53,9 M - -
Net cash position 2020 61,4 M - -
P/E ratio 2020 -7,85x
Yield 2020 -
Sales 2021 92,9 M - -
Net income 2021 -38,0 M - -
Net cash position 2021 37,6 M - -
P/E ratio 2021 -11,6x
Yield 2021 -
Capitalization 446 M 446 M -
EV / Sales 2020 6,27x
EV / Sales 2021 4,39x
Nbr of Employees 262
Free-Float 96,0%
More Financials
Company
SI-BONE, Inc. is focused on development of medical devices. The Company is engaged in the development, manufacture and commercialization of minimally invasive surgical devices for the treatment of patients with low back symptoms related to certain sacroiliac (SI) joint disorders. The Company offers iFuse Implant System, which provides a minimally invasive surgical solution to fuse the SI joint using patented... 
More about the company
Surperformance© ratings of SI-BONE, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on SI-BONE, INC.
06/17SI-BONE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/01SI-BONE, INC. : Entry into a Material Definitive Agreement, Termination of a Mat..
AQ
06/01SI-BONE, Inc. Announces $40 Million Debt Re-Financing
GL
05/29SI BONE : Announces Aetna Establishes Positive Coverage for MIS SI Joint Fusion ..
AQ
05/27Notice of Change of Location of Annual Meeting of Stockholders of SI-BONE, In..
GL
05/05SI BONE : Management's Discussion and Analysis of Financial Condition and Result..
AQ
05/05SI-BONE to Present at the Bank of America Securities 2020 Health Care Confere..
GL
05/04SI-BONE : 1Q Earnings Snapshot
AQ
05/04SI-BONE, INC. : Results of Operations and Financial Condition, Financial Stateme..
AQ
05/04SI-BONE, Inc. Reports First Quarter 2020 Financial Results
GL
04/22SI-BONE To Report First Quarter 2020 Financial Results on May 4, 2020
GL
04/02SI-BONE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
04/02SI-BONE, Inc. Provides Business Update in Response to COVID-19 Pandemic
GL
03/30SI-BONE, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
03/11SI BONE : Management's Discussion and Analysis of Financial Condition and Result..
AQ
More news
News in other languages on SI-BONE, INC.
06/17SI-BONE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
06/01SI-BONE, INC. : Entry into a Material Definitive Agreement, Termination of a Mat..
06/01SI-BONE, Inc. Announces $40 Million Debt Re-Financing
05/29SI BONE : Announces Aetna Establishes Positive Coverage for MIS SI Joint Fusion ..
05/27Notice of Change of Location of Annual Meeting of Stockholders of SI-BONE, In..
More news
Chart SI-BONE, INC.
Duration : Period :
SI-BONE, Inc. Technical Analysis Chart | SIBN | US8257041090 | MarketScreener
Technical analysis trends SI-BONE, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 23,86 $
Last Close Price 15,68 $
Spread / Highest target 78,6%
Spread / Average Target 52,2%
Spread / Lowest Target 27,6%
EPS Revisions
Managers
NameTitle
Jeffrey W. Dunn Chairman, President & Chief Executive Officer
Laura A. Francis Chief Operating & Financial Officer
Scott A. Yerby Chief Technology Officer
W. Carlton Reckling Chief Medical Officer & VP-Medical Affairs
Gregory K. Hinckley Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SI-BONE, INC.-27.07%446
ABBOTT LABORATORIES7.11%164 573
MASIMO CORPORATION46.23%12 508
ASAHI INTECC CO., LTD.-6.25%7 320
NOVOCURE LIMITED-28.35%6 065
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.95.28%5 682